Benzamide or benzamine compounds useful as anticancer agents for the treatment of human cancers
US11548894B2 · kind B2 · utility
0Cited by
11References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 24, 2018 |
| Grant date | Jan 10, 2023 |
| Priority date | — |
| Expiry date | Sep 24, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The described invention provides small molecule anti-cancer compounds for treating tumors that respond to cholesterol biosynthesis inhibition. The compounds selectively inhibit the cholesterol biosynthetic pathway in tumor-derived cancer cells, but do not affect normally dividing cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.